Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Gavvovidis, Ioannis Dr. (1) Kieback, Elisa Dr. (1) Leisegang, Matthias Dr. (3) Lorenz, Felix Dr. (3) Obenaus, Matthias (1) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (7) (-) Blankenstein, Thomas Prof. Dr. (3) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2006 (2) 2007 (1) 2008 (1) 2010 (1) 2011 (2) 2014 (1) (-) 2015 (2) 2016 (1) 2017 (1) (-) 2019 (1) Bioinformatics (1) Biology of Malignant Lymphomas (7) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (3) Molecular Immunology and Gene Therapy (9) Molecular Immunotherapy (2) Proteome Dynamics (1) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 3 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Molecular Cell Biology and Gene Therapy20152019 Sort: Result score Newest to oldest Oldest to newest January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
